These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 13381428

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Urinary amino acid excretion after carbonic anhydrase inhibition with diamox].
    SCHMIDT GW.
    Helv Paediatr Acta; 1955 May; 10(1-2):279-84. PubMed ID: 13241968
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Inhibition of hyperactivity and impulsivity by carbonic anhydrase inhibitors in spontaneously hypertensive rats, an animal model of ADHD.
    Yang MT, Lu DH, Chen JC, Fu WM.
    Psychopharmacology (Berl); 2015 Oct; 232(20):3763-72. PubMed ID: 26228972
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The carbonic anhydrase inhibitor acetazolamide exerts antidystonic effects in the dt(sz) mutant hamster.
    Richter A, Hamann M.
    Eur J Pharmacol; 2004 Oct 11; 502(1-2):105-8. PubMed ID: 15464095
    [Abstract] [Full Text] [Related]

  • 47. Oral administration of a potent carbonic anhydrase inhibitor ("Diamox"). I. Changes in electrolyte and acid-base balance.
    Leaf A, Schwartz WB, Relman AS.
    N Engl J Med; 1954 May 06; 250(18):759-64. PubMed ID: 13165895
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Patient tolerance to carbonic anhydrase inhibitors.
    Lichter PR, Newman LP, Wheeler NC, Beall OV.
    Am J Ophthalmol; 1978 Apr 06; 85(4):495-502. PubMed ID: 655230
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
    Biswas S, McKenna R, Supuran CT.
    Bioorg Med Chem Lett; 2013 Oct 15; 23(20):5646-9. PubMed ID: 23993330
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The use of carbonic anhydrase inhibitors in ophthalmology and clinical medicine.
    Wistrand PJ.
    Ann N Y Acad Sci; 1984 Oct 15; 429():609-19. PubMed ID: 6588916
    [No Abstract] [Full Text] [Related]

  • 56. Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.
    Supuran CT.
    Expert Opin Drug Metab Toxicol; 2016 Oct 15; 12(4):423-31. PubMed ID: 26878088
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition.
    Torring MS, Holmgaard K, Hessellund A, Aalkjaer C, Bek T.
    Invest Ophthalmol Vis Sci; 2009 Jan 15; 50(1):345-51. PubMed ID: 18757514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.